Stock listing

NASDAQ:NTRP Neurotrope Inc Stock

Follow Neurotrope Inc into a list and get an email when it puts out news.

Last close · NASDAQ:NTRP

$0.941 USD

Close on Dec 2, 2020 · No longer trades

Jan 12, 2017 to last close -87.4% · weekly closes, Jan 12, 2017 – Dec 2, 2020
Lowest – highest close
$0.645 – $28.600 USDSince Jan 12, 2017 · lowest Oct 11, 2019 · highest Mar 13, 2017

Delisted NASDAQ:NTRP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:NTRP
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Latest news

All Neurotrope Inc news

Neurotrope Inc on 6ix

News releases
21 in all · newest Dec 2, 2020 · oldest 2019
Decks
4 decks · latest Jan 8, 2018

Events

Next results
Jan 13, 2027 (expected)
QuarterResultsShare move
Quarter to Sep 30, 2026Oct 15, 2026 · After close−18.6%
Quarter to Jun 30, 2026Jul 15, 2026 · After close−18.6%
Quarter to Dec 31, 2025Jan 14, 2026 · After close−11.7%
Quarter to Sep 30, 2025Oct 15, 2025 · After close−12.6%
Quarter to Jun 30, 2025Jul 15, 2025 · After close+3.0%
Quarter to Mar 31, 2025May 29, 2025+5.1%
Quarter to Dec 31, 2024Jan 14, 2025 · After close−4.6%
Quarter to Sep 30, 2024Oct 15, 2024 · After close+5.0%
Quarter to Jun 30, 2024Aug 31, 2024−10.0%
Quarter to Mar 31, 2024May 31, 2024−7.3%
All 20 quarters
QuarterResultsShare move
Quarter to Sep 30, 2023Dec 28, 2023 · After close−5.2%
Quarter to Jun 30, 2023Aug 15, 2023−8.5%
Quarter to Mar 31, 2023May 16, 2023−13.4%
Quarter to Sep 30, 2022Nov 14, 2022+2.5%
Quarter to Jun 30, 2022Aug 5, 2022−18.9%
Quarter to Mar 31, 2022Apr 27, 2022−25.3%
Quarter to Dec 31, 2021Mar 25, 2022−4.8%
Quarter to Sep 30, 2021Oct 22, 2021−7.5%
Quarter to Jun 30, 2021Aug 5, 2021+6.3%
Quarter to Mar 31, 2021May 17, 2021+3.1%

Open Events

Decks

DeckKindSlidesDate
Technical Presentation (January 2018)Technical20 slidesJan 8, 2018
Investor Presentation (February 2016)Investor deck35 slidesFeb 23, 2016
Investor Presentation (January 2015)Investor deck20 slidesJan 14, 2015
Investor Presentation (January 2014)Investor deck22 slidesJan 13, 2014

Open Decks

Cap table

Built by 6ix from Neurotrope Inc’s releases · as of Oct 14, 2026

Common shares
15,229,900
Fully diluted
15,229,900

Fully diluted

LineSharesAs of
Common shares15,229,900Oct 14, 2026

Share count over time

CountShares
Oct 14, 202615,229,900

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Joshua N. Silverman
Other companies: Femasys Inc. (Director · Since at least Nov 21, 2023); PharmaCyte Biotech, Inc. (Interim Chief Executive Officer, President, and Director · Since at least Aug 15, 2022); TAO Synergies Inc. (Executive Chairman · Since at least Jun 4, 2021); Petros Pharmaceuticals Inc (Vice-Chairman of the Board · Since at least Dec 1, 2020); Q/C Technologies, Inc. (Executive Chairman · Since at least Sep 6, 2018); Fabric.AI, Inc. (Chief Executive Officer, Director · Since at least Aug 15, 2016); Marker Therapeutics, Inc. (Director · Nov 28, 2016 – Oct 16, 2018 · Past); Protagenic Therapeutics, Inc. (Director · Feb 12, 2016 – Feb 21, 2020 · Past); MGT Capital Investments, Inc. (Director · Dec 31, 2015 – Dec 31, 2015 · Past); National Holdings Corporation (Director · Jul 28, 2014 – Sep 12, 2016 · Past)
Director · Aug 4, 2016 – Dec 1, 2020 · Past
Robert Weinstein
Other companies: Petros Pharmaceuticals Inc (Chief Accounting Officer · Since at least Jun 18, 2026); PharmaCyte Biotech, Inc. (Director · Since at least Nov 14, 2022); TAO Synergies Inc. (Chief Financial Officer · Since at least Jun 4, 2021); XWELL, Inc. (Director & Chair of Audit Committee · Since at least Feb 3, 2020); TaoWeave, Inc. (Director · May 29, 2023 – May 29, 2023 · Past)
See Remarks · Nov 13, 2015 – Dec 1, 2020 · Past
Ivan P Gergel
Other companies: Corium International Inc (Director · Dec 4, 2014 – Nov 27, 2018 · Past); Nektar Therapeutics (SVP & Chief Medical Officer · May 19, 2014 – Nov 15, 2017 · Past); Endo International PLC (EVP, R&D and CSO · Mar 10, 2014 – Mar 10, 2014 · Past)
Director · Dec 13, 2018 – Dec 1, 2020 · Past
Jonathan L. Schechter
Other companies: TaoWeave, Inc. (Director · Since at least May 29, 2023); PharmaCyte Biotech, Inc. (Director · Since at least Aug 15, 2022); TAO Synergies Inc. (Director · Since at least Jun 4, 2021)
Director · Mar 15, 2019 – Dec 1, 2020 · Past
Charles Ryan
Other companies: Polaryx Therapeutics, Inc. (Director · Since at least Jan 29, 2026); Quince Therapeutics, Inc. (President · Since at least Sep 1, 2023)
Director · Nov 24, 2020 – Dec 1, 2020 · Past
Jay M Haft
Other companies: Kingstone Companies, Inc (Director · Mar 31, 2008 – Jan 3, 2020 · Past); Moscow Cablecom Corp (Director · Jan 3, 2006 – Jul 19, 2007 · Past)
Director · Aug 29, 2014 – Nov 30, 2015 · Past
Daniel L Alkon
Other companies: TAO Synergies Inc. (President and CSO, Director · Jun 4, 2021 – Dec 16, 2022 · Past)
See Remarks · Jan 22, 2019 – Dec 1, 2020 · Past
Michael CiraoloCOO and General Counsel · Apr 1, 2019 – Apr 15, 2019 · Past
Paula T TrzepaczSee Remarks · Jun 15, 2016 – Jun 15, 2016 · Past

Open People

Log in to ask 6ix AI your own questions about Neurotrope Inc.